Literature DB >> 16191501

A comparison of high-resolution melting analysis with denaturing high-performance liquid chromatography for mutation scanning: cystic fibrosis transmembrane conductance regulator gene as a model.

Lan-Szu Chou1, Elaine Lyon, Carl T Wittwer.   

Abstract

High-resolution melting analysis (HRMA) was compared with denaturing high-performance liquid chromatography (dHPLC) for mutation scanning of common mutations in the cystic fibrosis transmembrane conductance regulator gene. We amplified (polymerase chain reaction under conditions optimized for melting analysis or dHPLC) 26 previously genotyped samples with mutations in exons 3, 4, 7, 9, 10, 11, 13, 17b, and 21, including 20 different genotypes. Heterozygous mutations were detected by a change in shape of the melting curve or dHPLC tracing. All 20 samples with heterozygous mutations studied by both techniques were identified correctly by melting (100% sensitivity), and 19 were identified by dHPLC (95% sensitivity). The specificity of both methods also was good, although the dHPLC traces of exon 7 consistently revealed 2 peaks for wild-type samples, risking false-positive interpretation. Homozygous mutations could not be detected using curve shape by either method. However, when the absolute temperatures of HRMA were considered, G542X but not F508del homozygotes could be distinguished from wild type. HRMA easily detected heterozygotes in all single nucleotide polymorphism (SNP) classes (including A/T SNPs) and 1- or 2-base-pair deletions. HRMA had better sensitivity and specificity than dHPLC with the added advantage that some homozygous sequence alterations could be identified. HRMA has great potential for rapid, closed-tube mutation scanning.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16191501     DOI: 10.1309/BF3M-LJN8-J527-MWQY

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  31 in total

1.  Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.

Authors:  Xiaoyou Chen; Fanrong Kong; Qinning Wang; Chuanyou Li; Jianyuan Zhang; Gwendolyn L Gilbert
Journal:  J Clin Microbiol       Date:  2011-08-10       Impact factor: 5.948

2.  CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.

Authors:  Molly B Sheridan; Timothy W Hefferon; Nulang Wang; Christian Merlo; Carlos Milla; Drucy Borowitz; Eric D Green; Peter J Mogayzel; Garry R Cutting
Journal:  J Med Genet       Date:  2010-11-20       Impact factor: 6.318

Review 3.  High resolution melting applications for clinical laboratory medicine.

Authors:  Maria Erali; Karl V Voelkerding; Carl T Wittwer
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

4.  High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families.

Authors:  Aouatef Riahi; Maher Kharrat; Imen Lariani; Habiba Chaabouni-Bouhamed
Journal:  Fam Cancer       Date:  2014-12       Impact factor: 2.375

5.  Alternative reliable method for cytochrome P450 2D6 poor metabolizers genotyping.

Authors:  E Pindurová; A Zourková; J Zrůstová; J Juřica; A Pavelka
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

6.  Mutation analysis of SLC26A4 for Pendred syndrome and nonsyndromic hearing loss by high-resolution melting.

Authors:  Neng Chen; Lisbeth Tranebjærg; Nanna Dahl Rendtorff; Iris Schrijver
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

7.  High-resolution melting analysis of the TPMT gene: a study in the Polish population.

Authors:  Marzena Skrzypczak-Zielinska; Pawel Borun; Katarzyna Milanowska; Ludwika Jakubowska-Burek; Oliwia Zakerska; Agnieszka Dobrowolska-Zachwieja; Andrzej Plawski; Ursula G Froster; Marlena Szalata; Ryszard Slomski
Journal:  Genet Test Mol Biomarkers       Date:  2012-12-19

8.  Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors.

Authors:  Martin Pichler; Marija Balic; Elke Stadelmeyer; Christoph Ausch; Martina Wild; Christian Guelly; Thomas Bauernhofer; Hellmut Samonigg; Gerald Hoefler; Nadia Dandachi
Journal:  J Mol Diagn       Date:  2009-02-12       Impact factor: 5.568

9.  High-resolution melting analysis of cDNA-derived PCR amplicons for rapid and cost-effective identification of novel alleles in barley.

Authors:  Bernhard J Hofinger; Hai-Chun Jing; Kim E Hammond-Kosack; Kostya Kanyuka
Journal:  Theor Appl Genet       Date:  2009-07-04       Impact factor: 5.699

10.  Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  Marie-Pierre Audrezet; Aurélia Dabricot; Cédric Le Marechal; Claude Ferec
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.